Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Conference News ESC 2025

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

Michael O'Riordan

August 29, 2025

News Daily News

Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit

Michael O'Riordan

January 13, 2025

News Conference News HFSA 2024

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

L.A. McKeown

October 02, 2024

News Daily News

ACC/AHA Update Performance, Quality Measures for HF Care

Todd Neale

August 08, 2024

News Daily News

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

Michael O'Riordan

February 19, 2024

News Conference News AHA 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Shelley Wood

November 11, 2023

News Conference News HFSA 2023

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

Yael L. Maxwell

October 16, 2023

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2023

Shelley Wood

October 03, 2023

News Opinion Off Script

Parenthood vs Professional Opportunities: Let Your Priorities Be Your Guide

Michelle Kittleson, MD, PhD

September 25, 2023

News Features

Some Rays of Hope for ‘Sorry State’ of Transplant Rejection

Shelley Wood

May 08, 2023

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Conference News THT 2023

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Yael L. Maxwell

March 22, 2023

News Daily News

Vast Majority of HFrEF Patients Eligible for Vericiguat

L.A. McKeown

February 08, 2023

News Daily News

For Some, Hopes for a Heart Grow Dim as LVAD-Only Centers Spread

Michael O'Riordan

January 30, 2023

News Daily News

HF Deaths on the Rise in Young Adults, US Data Show

L.A. McKeown

August 03, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

BIO

Advertisement

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

ACC/AHA Update Performance, Quality Measures for HF Care

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

TCTMD’s Top 10 Most Popular Stories for September 2023

Parenthood vs Professional Opportunities: Let Your Priorities Be Your Guide

Some Rays of Hope for ‘Sorry State’ of Transplant Rejection

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Vast Majority of HFrEF Patients Eligible for Vericiguat

For Some, Hopes for a Heart Grow Dim as LVAD-Only Centers Spread

HF Deaths on the Rise in Young Adults, US Data Show

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Michelle Kittleson, MD, PhD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content